Teddy Amenabar,

Teddy Amenabar is a general assignment reporter based in Washington, D.C., covering health news with a focus on environmental health risks, social media trends, and fitness. He joined The Washington Post in 2015 after working as a contributing writer for Launcher, the newspaper's gaming and esports vertical. A graduate of the University of Maryland with a degree in journalism, Teddy has also served on The Post's audience team. In his work, Teddy strives to provide accurate and insightful reporting that informs and engages readers. He is committed to upholding the highest standards of professional integrity and fairness in his coverage. When not reporting, he enjoys staying active, exploring new restaurants in the city, and spending time with friends.

Biography:  https://www.washingtonpost.com/people/teddy-amenabar/

98%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

85%

Examples:

  • Five patients in the first study of CAR-T therapy for lupus saw their symptoms disappear and enter remission.
  • Researchers identified a 'molecular switch' in lupus that could stymie harmful immune response.
  • The new study about the underlying mechanisms of lupus was published in Nature on Wednesday.

Deceptions

95%

Examples:

  • But any potential treatment is still years away.
  • The hope for a cure is premature, but the study findings are 'a promising pathway to look at and think about in terms of providing a more sophisticated way of treating lupus.'
  • The study findings raise a 'compelling idea' for a novel way to treat lupus

Recent Articles

New Hope for Autoimmune Disorders: CAR-T Cell Therapies Show Promise in Treating Multiple Sclerosis and Lupus

New Hope for Autoimmune Disorders: CAR-T Cell Therapies Show Promise in Treating Multiple Sclerosis and Lupus

Broke On: Wednesday, 10 July 2024 Researchers are exploring new ways to use CAR-T cell therapies for treating autoimmune disorders like multiple sclerosis and lupus, following successful results in destroying pathogenic B cells in blood cancers. Kyverna Therapeutics' publication of clinical findings on engineered CAR-T cells depleting pathogenic B cells in progressive multiple sclerosis has accelerated research efforts.